202 related articles for article (PubMed ID: 32608537)
1. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
Yu H; Peng S; Chen X; Han S; Luo J
J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
Yin Y; Yang W; Zhang L; Liu K; Luo Z
Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
[TBL] [Abstract][Full Text] [Related]
3. The correlation of long non-coding RNA NEAT1 and its targets microRNA (miR)-21, miR-124, and miR-125a with disease risk, severity, and inflammation of allergic rhinitis.
Wang R; Xue S; Liu Y; Peng M; Guo B
Medicine (Baltimore); 2021 Jan; 100(4):e22946. PubMed ID: 33530155
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NEAT1 and its targets (microRNA-21 and microRNA-125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome.
Yang J; Wang S; Liu L; Wang J; Shao Y
J Clin Lab Anal; 2021 Dec; 35(12):e24076. PubMed ID: 34708894
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke.
Li P; Duan S; Fu A
J Clin Lab Anal; 2020 Feb; 34(2):e23056. PubMed ID: 31721299
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA NEAT1/microRNA-125a axis predicts increased major adverse cardiac and cerebrovascular event risk independently in patients with unprotected left main coronary artery disease underwent coronary artery bypass grafting.
Liu H; Yan X; Yu J
J Clin Lab Anal; 2020 Jul; 34(7):e23299. PubMed ID: 32185824
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis.
Zhang C; Chu M; Fan Y; Wu L; Li Z; Ma X; Zhuang W
J Clin Lab Anal; 2020 Sep; 34(9):e23400. PubMed ID: 32578294
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA NEAT 1 and its target microRNA-125a in sepsis: Correlation with acute respiratory distress syndrome risk, biochemical indexes, disease severity, and 28-day mortality.
Yang Y; Yang L; Liu Z; Wang Y; Yang J
J Clin Lab Anal; 2020 Dec; 34(12):e23509. PubMed ID: 32785981
[TBL] [Abstract][Full Text] [Related]
9. Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.
Wang W; Xie Y; Han X; Liu Y; Li P
Technol Cancer Res Treat; 2020; 19():1533033820935856. PubMed ID: 32799782
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expressions of circulating lncRNA NEAT1 and microRNA-125a are linked with Th2 cells and symptom severity in pediatric allergic rhinitis.
Wu X; Zhao S; Huang W; Huang L; Huang M; Luo X; Chang S
J Clin Lab Anal; 2022 Mar; 36(3):e24235. PubMed ID: 35064698
[TBL] [Abstract][Full Text] [Related]
11. Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients.
Zhao P; Zhao X
J Clin Lab Anal; 2021 Nov; 35(11):e23924. PubMed ID: 34564896
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
Bao Y; Wei M; Ji X
J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
[TBL] [Abstract][Full Text] [Related]
13. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients.
Zhou F; Guo L
Hematology; 2022 Dec; 27(1):596-602. PubMed ID: 35617291
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NEAT1 overexpression associates with increased exacerbation risk, severity, and inflammation, as well as decreased lung function through the interaction with microRNA-124 in asthma.
Li X; Ye S; Lu Y
J Clin Lab Anal; 2020 Jan; 34(1):e23023. PubMed ID: 31876058
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomas.
Ma Y; Liu L; Yan F; Wei W; Deng J; Sun J
World J Surg Oncol; 2016 Feb; 14(1):41. PubMed ID: 26911892
[TBL] [Abstract][Full Text] [Related]
16. Identification of long noncoding RNA
Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA ANRIL interacts with microRNA-34a and microRNA-125a, and they all correlate with disease risk and severity of Parkinson's disease.
Yang P; Lin G; Wang M; Chen X; Huang J
J Clin Lab Anal; 2022 Jan; 36(1):e24037. PubMed ID: 34921567
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.
Sedlarikova L; Gromesova B; Kubaczkova V; Radova L; Filipova J; Jarkovsky J; Brozova L; Velichova R; Almasi M; Penka M; Bezdekova R; Stork M; Adam Z; Pour L; Krejci M; Kuglík P; Hajek R; Sevcikova S
Eur J Haematol; 2017 Sep; 99(3):223-233. PubMed ID: 28543758
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients.
Liu W; Geng F; Yu L
J Clin Lab Anal; 2020 Jun; 34(6):e23222. PubMed ID: 32309886
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients.
Xiang Y; Xu X; Yang B; Wu Z; Jiang R; Xie Y
Ir J Med Sci; 2022 Apr; 191(2):671-679. PubMed ID: 33864191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
